Viewing Study NCT02063295

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2026-02-27 @ 8:26 AM
Study NCT ID: NCT02063295
Status: COMPLETED
Last Update Posted: 2016-07-18
First Post: 2014-02-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury
Sponsor: Zafgen, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
None Over-weight View
None Hypothalamic Injury View
None Craniopharyngioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Beloranib View
None ZGN-440 View
None ZGN-440 for injectable suspension View
None ZGN-433 View